<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
<ListRecords>
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/oai_dc/"
           xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
           xmlns:dc="http://purl.org/dc/elements/1.1/"
           xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
           xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   	<dc:title>Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors</dc:title>
   	<dc:creator>Sreeramkumar, Vinatha</dc:creator>
   	<dc:creator>Hons, Miroslav ; https://orcid.org/0000-0002-6625-3348</dc:creator>
   	<dc:creator>Punzón, Carmen</dc:creator>
   	<dc:creator>Stein, Jens</dc:creator>
   	<dc:creator>Sancho, David</dc:creator>
   	<dc:creator>Fresno Forcelledo, Manuel</dc:creator>
   	<dc:creator>Cuesta, Natalia</dc:creator>
   	<dc:description>Understanding the regulation of T-cell responses during inflammation and auto-immunity is fundamental for designing efficient therapeutic strategies against immune diseases. In this regard, prostaglandin E 2 (PGE 2) is mostly considered a myeloid-derived immunosuppressive molecule. We describe for the first time that T cells secrete PGE 2 during T-cell receptor stimulation. In addition, we show that autocrine PGE 2 signaling through EP receptors is essential for optimal CD4 + T-cell activation in vitro and in vivo, and for T helper 1 (Th1) and regulatory T cell differentiation. PGE 2 was found to provide additive co-stimulatory signaling through AKT activation. Intravital multiphoton microscopy showed that triggering EP receptors in T cells is also essential for the stability of T cell-dendritic cell (DC) interactions and Th-cell accumulation in draining lymph nodes (LNs) during inflammation. We further demonstrated that blocking EP receptors in T cells during the initial phase of collagen-induced arthritis in mice resulted in a reduction of clinical arthritis. This could be attributable to defective T-cell activation, accompanied by a decline in activated and interferon-γ-producing CD4 + Th1 cells in draining LNs. In conclusion, we prove that T lymphocytes secret picomolar concentrations of PGE 2, which in turn provide additive co-stimulatory signaling, enabling T cells to attain a favorable activation threshold. PGE 2 signaling in T cells is also required for maintaining long and stable interactions with DCs within LNs. Blockade of EP receptors in vivo impairs T-cell activation and development of T cell-mediated inflammatory responses. This may have implications in various pathophysiological settings.</dc:description>
   	<dc:publisher>Nature Publishing Group</dc:publisher>
   	<dc:date>2016</dc:date>
   	<dc:type>info:eu-repo/semantics/article</dc:type>
   	<dc:type>doc-type:Article</dc:type>
   	<dc:type>Article</dc:type>
   	<dc:type>http://purl.org/coar/resource_type/c_2df8fbb1</dc:type>
   	<dc:identifier>https://research-explorer.ista.ac.at/record/1217</dc:identifier>
   	<dc:source>Sreeramkumar V, Hons M, Punzón C, et al. Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors. &lt;i&gt;Immunology and Cell Biology&lt;/i&gt;. 2016;94(1):39-51. doi:&lt;a href=&quot;https://doi.org/10.1038/icb.2015.62&quot;&gt;10.1038/icb.2015.62&lt;/a&gt;</dc:source>
   	<dc:language>eng</dc:language>
   	<dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/icb.2015.62</dc:relation>
   	<dc:relation>info:eu-repo/semantics/altIdentifier/wos/000367628600005</dc:relation>
   	<dc:rights>info:eu-repo/semantics/closedAccess</dc:rights>
</oai_dc:dc>
</ListRecords>
</OAI-PMH>
